中梁控股(02772.HK)優先票據及CB修訂契約條款獲必要比重持有人同意
中梁控股(02772.HK)公布,就2027年到期5%優先票據及2027年到期3%可換股債券的契約條款修訂,同意徵求期限已於上周五(13日)屆滿,公司共接獲未到期票據本金總額約82%持有人及未到期債券本金總額約92%持有人的同意書,因此已取得實施建議修訂的必要同意。公司、附屬公司擔保人及受託人已於昨日(16日)簽訂有關證券的補充契約,並交付予受託人,建議修訂已生效,並對所有相關證券持有人(包括不同意持有人)具約束力。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.